STAGE IIIC GASTRIC CANCER AJCC V7
Clinical trials for STAGE IIIC GASTRIC CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC GASTRIC CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIC GASTRIC CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise for Hard-to-Treat stomach cancers
Disease control OngoingThis study is for people with specific types of stomach cancer (mismatch repair deficient or Epstein-Barr virus positive) that can be surgically removed. It tests whether giving the immunotherapy drug pembrolizumab before and after standard chemotherapy and radiation can help pre…
Matched conditions: STAGE IIIC GASTRIC CANCER AJCC V7
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
New drug combo aims to boost Radiation's punch against tough GI cancers
Symptom relief OngoingThis early-phase study tested an oral drug called ropidoxuridine (IPdR) in 19 people with advanced gastrointestinal cancers that could not be cured. The goal was to find the safest dose and see if the drug could make tumor cells more sensitive to radiation therapy. The study focu…
Matched conditions: STAGE IIIC GASTRIC CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 17, 2026 04:15 UTC